18F-FAPI-42 PET检测扩张型心肌病心脏成纤维细胞活化的研究:与组织病理学和心脏磁共振的比较
本研究纳入19例扩张型心肌病患者行18F-FAPI-42 PET/CT显像,其中14例同时行心脏PET/心脏磁共振检查,4例在PET扫描后9至124天内接受心脏移植。结果显示18F-FAPI PET可检测扩张型心肌病心肌成纤维细胞活化,其摄取与组织学标志物及心脏功能参数相关,代谢活跃体积是评估病情的有效指标。
要点
- 18F-FAPI-42 PET识别出的异常节段数(n=168)多于CMR-LGE(n=95)。
- 在FAPI阳性节段中,T1增强后值和细胞外容积百分比高于FAPI阴性节段(n=56)。
- 随NYHA功能分级从Ⅱ级进展至Ⅳ级,代谢活跃体积持续增加。
核心结论
- 18F-FAPI PET能够检测扩张型心肌病心肌中的成纤维细胞活化,并与组织学标志物和心脏功能参数强相关;代谢活跃体积是评估扩张型心肌病病情的有效指标,最大标准化摄取值和总病灶FAPI可能具有预后价值。
研究设计与样本
- 共19例扩张型心肌病患者接受18F-FAPI-42 PET/CT显像,其中14例同时接受心脏PET/心脏磁共振检查,4例在PET扫描后9至124天内接受心脏移植;另设对照组以建立18F-FAPI活性和CMR参数的正常范围;采用Spearman相关分析评估18F-FAPI摄取与胶原纤维沉积程度、FAP荧光、超声心动图及PET/CMR获得的心脏功能参数之间的相关性。
关键影像表现/征象
- 18F-FAPI PET显示扩张型心肌病患者心肌不同区域存在不同程度的FAPI摄取,显著高于对照组。
- 18F-FAPI-42 PET识别出的异常节段数(n=168)多于CMR-LGE(n=95)。
- 在FAPI阳性节段中,T1增强后值和细胞外容积百分比高于FAPI阴性节段(n=56),且心肌长轴径向PS%能力受损更严重。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Myocardial fibrosis (MF) is a key pathophysiological characteristic of dilated cardiomyopathy (DCM). Radiolabeled imaging agents targeting fibroblast activation protein (FAP) enhance the accuracy and sensitivity for detecting early-stage myocardial fibrosis.
OBJECTIVES: This study aimed to evaluate the feasibility of using 18F-labeled FAP inhibitor tracer (FAPI-42) positron emission tomography (PET) imaging for detecting myocardial fibroblast activation and fibrosis in DCM patients.
METHODS: In total, 19 DCM patients underwent 18F-FAPI-42 PET/computed tomography imaging, with 14 also underwent cardiac PET/cardiac magnetic resonance (CMR). Four patients underwent cardiac transplantation within 9 to 124 days after PET scans. Control groups were enrolled to establish the normal range of 18F-FAPI activity and CMR parameters. Spearman correlation analysis assessed correlations between 18F-FAPI uptake, the degree of collagen fiber deposition and FAP fluorescence, cardiac function parameters obtained from echocardiography, and PET/CMR.
RESULTS: 18F-FAPI PET imaging revealed varying degrees of FAPI uptake across diverse regions of the myocardium in DCM patients, significantly higher than the control group. 18F-FAPI-42 PET identified more abnormal segments (n = 168) than CMR-LGE (n = 95). Furthermore, in FAPI-positive segments, the T1-postcontrast values and extracellular volume % were higher than in FAPI-negative segments (n = 56). Additionally, the myocardial long-axis radial PS% capacity was more severely impaired. In heart transplant patients, the FAPI uptake strongly correlated with FAP mean fluorescence intensity (P < 0.001) and collagen fiber deposition (P < 0.05). The FAPI uptake also correlated with cardiac function parameters assessed by CMR (end-systolic volume, end-diastolic volume, left ventricular ejection fraction %, and extracellular volume %). As NYHA functional class progressed from Ⅱ to Ⅳ, metabolically active volume increased consistently. However, maximum standardized uptake value and total lesion FAPI initially increasing and then subsequently declining.
CONCLUSIONS: 18F-FAPI PET is capable of detecting fibroblast activation in the myocardium of DCM, strongly correlating with histological markers and cardiac function parameters. Metabolically active volume is an effective indicator for assessing the condition of DCM, whereas maximum standardized uptake value and total lesion FAPI may potentially offer prognosis values.
引用
- Liang S, Hou P, Wang X, et al. Comparison of 18F-FAPI-42 PET for Detecting Cardiac Fibroblast Activation in Dilated Cardiomyopathy With Histopathology and CMR. JACC Cardiovasc Imaging. 2025. PMID: 40742355. doi:10.1016/j.jcmg.2025.05.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。